Vascular calcification in animal models of CKD: A review

American Journal of Nephrology

Volumn 31, Issue 6, 2010, Pages 471-481

  Shobeiri, Navid ^a   Adams, Michael A ^a   Holden, Rachel M ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Cardiovascular mortality; Chronic kidney disease; Vascular calcification

Indexed keywords

22 OXACALCITRIOL; ADENINE; ALENDRONIC ACID; AMG 641; AMMONIUM CHLORIDE; CALCIMIMETIC AGENT; CALCITRIOL; CALCIUM; CALCIUM SENSING RECEPTOR ANTAGONIST; CATHEPSIN S; CINACALCET; ETIDRONIC ACID; FETUIN A; IBANDRONIC ACID; OSTEOGENIC PROTEIN 1; PAMIDRONIC ACID; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE; PHOSPHATE BINDING AGENT; R 568; RECEPTOR BLOCKING AGENT; SEVELAMER; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE;

ANIMAL MODEL; AORTA DISEASE; ARTERY CALCIFICATION; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CAUTERIZATION; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DISEASE MODEL; DISEASE SEVERITY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; KIDNEY FAILURE; KNOCKOUT MOUSE; MOUSE; NEPHRECTOMY; NONHUMAN; PHENOTYPE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RAT; RENAL OSTEODYSTROPHY; REVIEW; SOFT TISSUE CALCIFICATION; SPRAGUE DAWLEY RAT; TRANSGENIC ANIMAL; TRANSGENIC MOUSE; VALVULAR HEART DISEASE; WISTAR RAT; ANIMAL; CALCINOSIS; CHRONIC KIDNEY FAILURE; PATHOLOGY; VASCULAR DISEASE;

ANIMALS; CALCINOSIS; DISEASE MODELS, ANIMAL; HUMANS; MICE; RENAL INSUFFICIENCY, CHRONIC; VASCULAR DISEASES;

EID: 77951033351     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000299794     Document Type: Review

References (58)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in endstage renal disease. Hypertension 2001; 38: 938-942.
2. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.
3. Hujairi NM, Afzali B, Goldsmith DJ: Cardiac calcification in renal patients: what we do and don't know. Am J Kidney Dis 2004; 43: 234-243.
4. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL: Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87: 1055-1062.
5. London GM, Marchais SJ, Guerin AP, Metivier F: Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 2005; 14: 525-531.
6. Reynolds JL, Joannides AJ, Skepper JN, Mc-Nair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867.
7. Shanahan CM, Proudfoot D, Tyson KL, Cary NR, Edmonds M, Weissberg PL: Expression of mineralisation-regulating proteins in association with human vascular calcification. Z Kardiol 2000; 89(suppl 2):63-68.
8. Shroff RC, Shanahan CM: The vascular biology of calcification. Semin Dial 2007; 20: 103-109.
9. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268.
10. Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimbrone MA Jr, Falb D, Huszar D: A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 2000; 24: 171-174.
11. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
12. Chauntin A, Ferris EB: Experimental renal insufficiency produced by partial nephrectomy. Arch Intern Med 1932; 49: 767-787.
13. Ejerblad S, Eriksson I, Johansson H: Uraemic arterial disease. An experimental study with special reference to the effect of parathyroidectomy. Scand J Urol Nephrol 1979; 13: 161-169. (Pubitemid 9254520)
14. Gagnon RF, Duguid WP: A reproducible model for chronic renal failure in the mouse. Urol Res 1983; 11: 11-14.
15. Yokozawa T, Oura H, Okada T: Metabolic effects of dietary purine in rats. J Nutr Sci Vitaminol (Tokyo) 1982; 28: 519-526.
16. Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123: 1939-1951.
17. Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E: Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in longterm experimental uremia. Kidney Int 2003; 64: 1653-1661.
18. Cardus A, Panizo S, Parisi E, Fernandez E, Valdivielso JM: Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 2007; 22: 860-866.
19. Hirata M, Katsumata K, Endo K, Fukushima N, Ohkawa H, Fukagawa M: In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3. Nephrol Dial Transplant 2003; 18: 1770-1776.
20. Wu-Wong JR, Noonan W, Ma J, Dixon D, Nakane M, Bolin AL, Koch KA, Postl S, Morgan SJ, Reinhart GA: Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 2006; 318: 90-98.
21. Lopez I, Mendoza FJ, Guilera-Tejero E, Perez J, Guerrero F, Martin D, Rodriguez M: The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int 2008; 73: 300-307.
22. Henley C, Colloton M, Cattley RC, Shatzen E, Towler DA, Lacey D, Martin D: 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1370-1377.
23. Tamura K, Suzuki Y, Matsushita M, Fujii H, Miyaura C, Aizawa S, Kogo H: Prevention of aortic calcification by etidronate in the renal failure rat model. Eur J Pharmacol 2007; 558: 159-166.
24. Mendoza FJ, Lopez I, Montes de OA, Perez J, Rodriguez M, guilera-Tejero E: Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int 2008; 73: 407-414.
25. Westenfeld R, Schafer C, Smeets R, Brandenburg VM, Floege J, Ketteler M, Jahnen-Dechent W: Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 2007; 22: 1537-1546.
26. Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, Iwamoto Y, Fukuda D, Kohler RH, Shi GP, Jaffer FA, Weissleder R: Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 2009; 119: 1785-1794.
27. Phan O, Ivanovski O, Nguyen-Khoa T, Mothu N, Angulo J, Westenfeld R, Ketteler M, Meert N, Maizel J, Nikolov IG, Vanholder R, Lacour B, Drueke TB, Massy ZA: Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation 2005; 112: 2875-2882. (Pubitemid 41641683)
28. Phan O, Ivanovski O, Nikolov IG, Joki N, Maizel J, Louvet L, Chasseraud M, Nguyen-Khoa T, Lacour B, Drueke TB, Massy ZA: Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure. Nephrol Dial Transplant 2008; 23: 82-90.
29. Mathew S, Lund RJ, Strebeck F, Tustison KS, Geurs T, Hruska KA: Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol 2007; 18: 122-130.
30. Chertow GM, Burke SK, Dillon MA, Slatopolsky E: Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients. Nephrol Dial Transplant 1999; 14: 2907-2914.
31. Sadek T, Mazouz H, Bahloul H, Oprisiu R, El Esper N, El Esper I, Boitte F, Brazier M, Moriniere P, Fournier A: Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs. calcium carbonate in dialysis patients: an open-label, randomized study. Nephrol Dial Transplant 2003; 18: 582-588.
32. Ferramosca E, Burke S, Chasan-Taber S, Ratti C, Chertow GM, Raggi P: Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. Am Heart J 2005; 149: 820-825.
33. Katsumata K, Kusano K, Hirata M, Tsunemi K, Nagano N, Burke SK, Fukushima N: Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 2003; 64: 441-450.
34. Davies MR, Lund RJ, Hruska KA: BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 2003; 14: 1559-1567.
35. Davies MR, Lund RJ, Mathew S, Hruska KA: Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 2005; 16: 917-928.
36. Price PA, Roublick AM, Williamson MK: Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70: 1577-1583.
37. Henley C, Davis J, Miller G, Shatzen E, Cattley R, Li X, Martin D, Yao W, Lane N, Shalhoub V: The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. Eur J Pharmacol 2009; 616: 306-313.
38. Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Rakugi H, Imai E, Isaka Y: Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int 2009; 75: 915-928.
39. Terai K, Nara H, Takakura K, Mizukami K, Sanagi M, Fukushima S, Fujimori A, Itoh H, Okada M: Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels. Br J Pharmacol 2009; 156: 1267-1278.
40. Moe SM, Chen NX, Seifert MF, Sinders RM, Duan D, Chen X, Liang Y, Radcliff JS, White KE, Gattone VH: A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 2009; 75: 176-184.
41. Persy V, Postnov A, Neven E, Dams G, De Broe M, D'Haese P, De Clerck N: High-resolution X-ray microtomography is a sensitive method to detect vascular calcification in living rats with chronic renal failure. Arterioscler Thromb Vasc Biol 2006; 26: 2110-2116.
42. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252.
43. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P: Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824.
44. Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P: Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol 2007; 2: 898-905.
45. Lopez I, Guilera-Tejero E, Mendoza FJ, Almaden Y, Perez J, Martin D, Rodriguez M: Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol. J Am Soc Nephrol 2006; 17: 795-804.
46. Hill JA, Goldin JG, Gjertson D, Emerick AM, Greaser LD, Yoon HC, Khorrami S, Aziz D, Adams JS: Progression of coronary artery calcification in patients taking alendronate for osteoporosis. Acad Radiol 2002; 9: 1148-1152.
47. Haut LL, Alfrey AC, Guggenheim S, Buddington B, Schrier N: Renal toxicity of phosphate in rats. Kidney Int 1980; 17: 722-731.
48. Mizobuchi M, Ogata H, Hatamura I, Koiwa F, Saji F, Shiizaki K, Negi S, Kinugasa E, Ooshima A, Koshikawa S, Akizawa T: Upregulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism. Nephrol Dial Transplant 2006; 21: 911-916.
49. Graciolli FG, Neves KR, Dos Reis LM, Graciolli RG, Noronha IL, Moyses RM, Jorgetti V: Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia. Nephrol Dial Transplant 2009; 24: 1416-1421.
50. Krog M, Ejerblad S, Eriksson I, Johansson H: Arterial calcifications in uraemic rats treated with 1-alpha-hydroxycholecalciferol and parathyroidectomy. Scand J Urol Nephrol 1984; 18: 227-239.
51. Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drueke TB, Muntzel MS: Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 2005; 16: 109-116.
52. Ivanovski O, Szumilak D, Nguyen-Khoa T, Nikolov IG, Joki N, Mothu N, Maizel J, Westenfeld R, Ketteler M, Lacour B, Drueke TB, Massy ZA: Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure. J Urol 2008; 179: 1631-1636.
53. Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri R, Maizel J, Hamada Y, Nguyen-Khoa T, Fukagawa M, Kamel S, Lacour B, Drueke TB, Massy ZA: The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE -/- ) mice. Atherosclerosis 2009; 205: 55-62.
54. Maizel J, Six I, Slama M, Tribouilloy C, Sevestre H, Poirot S, Giummelly P, Atkinson J, Choukroun G, Andrejak M, Kamel S, Maziere JC, Massy ZA: Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification. Circulation 2009; 119: 306-313.
55. Tamagaki K, Yuan Q, Ohkawa H, Imazeki I, Moriguchi Y, Imai N, Sasaki S, Takeda K, Fukagawa M: Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant 2006; 21: 651-659.
56. Neven E, Dauwe S, De Broe ME, D'Haese PC, Persy V: Endochondral bone formation is involved in media calcification in rats and in men. Kidney Int 2007; 72: 574-581.
57. Neven E, Dams G, Postnov A, Chen B, De CN, De Broe ME, D'Haese PC, Persy V: Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats. Nephrol Dial Transplant 2009; 24: 1790-1799.
58. Lomashvili KA, Monier-Faugere MC, Wang X, Malluche HH, O'Neill WC: Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 2009; 75: 617-625.